A detailed history of Quarry LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Quarry LP holds 6,000 shares of SWTX stock, worth $234,120. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,000
Previous 5,000 20.0%
Holding current value
$234,120
Previous $188 Million 2.07%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.04 - $42.76 $32,040 - $42,760
1,000 Added 20.0%
6,000 $192 Million
Q2 2024

Aug 14, 2024

BUY
$36.06 - $47.62 $64,908 - $85,716
1,800 Added 56.25%
5,000 $188 Million
Q1 2024

May 15, 2024

SELL
$36.5 - $52.5 $20,075 - $28,875
-550 Reduced 14.67%
3,200 $158 Million
Q4 2023

Feb 14, 2024

SELL
$18.94 - $37.24 $14,564 - $28,637
-769 Reduced 17.02%
3,750 $137 Million
Q3 2023

Nov 14, 2023

BUY
$23.12 - $31.38 $104,479 - $141,806
4,519 New
4,519 $104 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.43B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.